INNO-GENE

The current price of IGN is 1.800 PLN — it has increased by 4.65% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange INNO-GENE stocks are traded under the ticker IGN.

IGN stock is 4.44% volatile and has beta coefficient of 0.84. Check out the list of the most volatile stocks — is INNO-GENE there?

Yes, you can track INNO-GENE financials in yearly and quarterly reports right on TradingView.

IGN stock hasn't changed in a week, the month change is a 6.51% rise, over the last year INNO-GENE has showed a 65.12% decrease.

IGN net income for the last quarter is ‪−148.00 K‬ PLN, while the quarter before that showed ‪−561.00 K‬ PLN of net income which accounts for 73.62% change. Track more INNO-GENE financial stats to get the full picture.

No, IGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, IGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNO-GENE stock right from TradingView charts — choose your broker and connect to your account.

IGN reached its all-time high on Oct 9, 2020 with the price of 98.800 PLN, and its all-time low was 0.880 PLN and was reached on Feb 15, 2019.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 10.00 employees. See our rating of the largest employees — is INNO-GENE on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNO-GENE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNO-GENE stock shows the sell signal. See more of INNO-GENE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNO-GENE EBITDA is ‪−2.26 M‬ PLN, and current EBITDA margin is −183.24%. See more stats in INNO-GENE financial statements.